Analysts think CSBR stock price could increase by 20%
Jun 14, 2024, 6:28 AM
-1.08%
What does CSBR do
Champions Oncology, Inc., based in Baltimore, Maryland, develops and sells technology solutions for personalizing oncology drug development, employing 230 people and operating a dual regulatory/non-regulatory research center. The firm offers TumorGraft Technology Platform services and leverages Lumin Bioinformatics software alongside AI for drug discovery and development.
3 analysts think CSBR stock price will increase by 19.77%. The current median analyst target is $6.12 compared to a current stock price of $5.11. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
